1057107-39-7 Usage
Uses
Used in Pharmaceutical Industry:
4-(2-(Methoxycarbonyl)cyclopropyl)benzoic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds, specifically for the preparation of 6-acylaminoisoquinolines. These compounds serve as kinase inhibitors, which are crucial in the development of targeted therapies for cancer and other diseases where kinases play a significant role in the disease progression.
The compound's unique structure allows for the formation of 6-acylaminoisoquinolines with potential inhibitory effects on specific kinases, thus providing a valuable tool in the development of novel therapeutic agents. By targeting these enzymes, 4-(2-(Methoxycarbonyl)cyclopropyl)benzoic acid and its derivatives can contribute to the advancement of personalized medicine and the treatment of various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1057107-39-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,7,1,0 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1057107-39:
(9*1)+(8*0)+(7*5)+(6*7)+(5*1)+(4*0)+(3*7)+(2*3)+(1*9)=127
127 % 10 = 7
So 1057107-39-7 is a valid CAS Registry Number.
1057107-39-7Relevant articles and documents
6-Aminoisoquinoline Compounds
-
Page/Page column 17, (2008/12/06)
6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.
